Korea develops artificial bone for clinical trials

The artificial bone, developed by Daewoon Pharm and Bioalpha Co. for the first time in Korea, has obtained official approval from the Korea Food and Drug Administration for clinical trials.

This trials for 126 patients, who require spinal fusion surgery, will be conducted for two years in three major hospitals in Korea Seoul National University Hospital, Seoul Asan Hospital and Seoul Samsun...